ATTENTION! New storage temperature requirements for Polyoxidonium®

Polyoxidonium®, an effective and safe immunomodulator with a combination of pharmacological properties, now has new storage temperature requirements.

This unique drug, developed and manufactured by Petrovax Group, has been successfully used in clinical practice for 15 years.

Starting December 2010, from series 220610 (Registration Certificate Р№002 935/04-050510) on, the recommended temperature range for Polyoxidonium® in 12 mg tablets changed to 4–250С.

Packages of Polyoxidonium® in 12 mg tablets can be stored at room temperature, making them easier to transport and use, while maintaining the consistently high effectiveness and safety of this product.

Previous news

Pfizer and NPO Petrovax Pharm to jointly manufacture a pneumococcal conjugate vaccine